These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8847528)

  • 1. A minimal and optimal cytotoxic T cell epitope within hepatitis C virus nucleoprotein.
    Kita H; Hiroishi K; Moriyama T; Okamoto H; Kaneko T; Ohnishi S; Yazaki Y; Imawari M
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3189-93. PubMed ID: 8847528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new cytotoxic T cell epitopes identified within the hepatitis C virus nucleoprotein.
    Kaneko T; Nakamura I; Kita H; Hiroishi K; Moriyama T; Imawari M
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1305-9. PubMed ID: 8683220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA B44-restricted cytotoxic T lymphocyte responses to the peptides of HCV nucleoprotein residues 81-100 in patients with chronic hepatitis C.
    Kita H; Moriyama T; Kaneko T; Okamoto H; Hiroishi K; Ohnishi S; Imawari M
    J Gastroenterol; 1995 Dec; 30(6):809-12. PubMed ID: 8963405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
    Kita H; Moriyama T; Kaneko T; Harase I; Nomura M; Miura H; Nakamura I; Yazaki Y; Imawari M
    Hepatology; 1993 Nov; 18(5):1039-44. PubMed ID: 7693568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
    Hiroishi K; Kita H; Kojima M; Okamoto H; Moriyama T; Kaneko T; Ishikawa T; Ohnishi S; Aikawa T; Tanaka N; Yazaki Y; Mitamura K; Imawari M
    Hepatology; 1997 Mar; 25(3):705-12. PubMed ID: 9049223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis.
    Ibe M; Sakaguchi T; Tanaka K; Saito S; Yokota S; Tanaka T; Shimotohno K; Chujoh Y; Shiratori Y; Omata M; Miwa K; Takiguchi M
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1735-44. PubMed ID: 9680137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Forecasting of hepatitis C virus CTL epitopes and design of multi-epitopes vaccine].
    Li D; Xie YW; Xue XP; Bai XF; Jia ZS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):786-7. PubMed ID: 19874698
    [No Abstract]   [Full Text] [Related]  

  • 9. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
    Townsend AR; Rothbard J; Gotch FM; Bahadur G; Wraith D; McMichael AJ
    J Immunol; 2006 May; 176(9):5141-50. PubMed ID: 16621977
    [No Abstract]   [Full Text] [Related]  

  • 10. A helper T-cell antigen enhances generation of hepatitis C virus-specific cytotoxic T lymphocytes in vitro.
    Kita H; Moriyama T; Kaneko T; Hiroishi K; Harase I; Miura H; Nakamura I; Inamori H; Kodama T; Ohnishi S
    J Med Virol; 1995 Apr; 45(4):386-91. PubMed ID: 7545209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
    Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
    Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T lymphocyte responses in hepatitis C virus infection.
    Imawari M; Kita H; Moriyama T; Kaneko T; Hiroishi K
    Princess Takamatsu Symp; 1995; 25():221-5. PubMed ID: 8875627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helper T cell determinant peptide contributes to induction of cellular immune responses by peptide vaccines against hepatitis C virus.
    Hiranuma K; Tamaki S; Nishimura Y; Kusuki S; Isogawa M; Kim G; Kaito M; Kuribayashi K; Adachi Y; Yasutomi Y
    J Gen Virol; 1999 Jan; 80 ( Pt 1)():187-193. PubMed ID: 9934701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitro.
    Langhans B; Schweitzer S; Nischalke HD; Braunschweiger I; Sauerbruch T; Spengler U
    J Infect Dis; 2004 Jan; 189(2):248-53. PubMed ID: 14722889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus.
    Gao XM; Liew FY; Tite JP
    J Immunol; 1989 Nov; 143(9):3007-14. PubMed ID: 2478631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ; Wang WL; Wang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
    Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
    J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Mar; 76(5):2567-72. PubMed ID: 11836437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
    Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.